Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 8

Have you been tested and confirmed to be HLA-A*02:01 positive?

This is a genetic requirement for the study drug to be effective. Without this marker, the treatment cannot work properly. You will need genetic testing to confirm this if you haven't had it done.

Show original medical criteria

HLA-A*02:01 is a genetic marker required for this immunotherapy to work. The drug tebentafusp-tebn is designed to target cancer cells in patients with this specific genetic type.

This is informational only — not medical advice. Always discuss eligibility with your oncologist.